Bone Biologics Corp (BBLG) › Cash & EquivalentsBone Biologics Corp (BBLG) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $02012: $2.4K2013: $1.5K2014: $2.66M2015: $1.12M2016: $620.4K2017: $690.3K2018: $955.4K2019: $24.1K2021: $6.68M$6.68M2011Cash & Equivalents (USD)2021Fiscal YearCash & EquivalentsChange YoY2021$6.68M—2019$24.1K-97.5%2018$955.4K+38.4%2017$690.3K+11.3%2016$620.4K-44.4%2015$1.12M-58.1%2014$2.66M+172942.7%2013$1.5K-35.1%2012$2.4K—2011$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share